131 related articles for article (PubMed ID: 12172384)
1. Triptans reduce the inflammatory response in bacterial meningitis.
Hoffmann O; Keilwerth N; Bille MB; Reuter U; Angstwurm K; Schumann RR; Dirnagl U; Weber JR
J Cereb Blood Flow Metab; 2002 Aug; 22(8):988-96. PubMed ID: 12172384
[TBL] [Abstract][Full Text] [Related]
2. S+ -flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater.
Zimmermann K; Reeh WP; Averbeck B
Pain; 2003 Jun; 103(3):313-320. PubMed ID: 12791437
[TBL] [Abstract][Full Text] [Related]
3. Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibers of the supratentorial dura mater in an experimental migraine model.
Knyihár-Csillik E; Tajti J; Chadaide Z; Csillik B; Vécsei L
Microsc Res Tech; 2001 May; 53(3):193-211. PubMed ID: 11301495
[TBL] [Abstract][Full Text] [Related]
4. [Zolmitriptan].
Monseu G; Sternon J
Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of rat cranial dura mater with potassium chloride causes CGRP release into the cerebrospinal fluid and increases medullary blood flow.
Dux M; Will C; Eberhardt M; Fischer MJM; Messlinger K
Neuropeptides; 2017 Aug; 64():61-68. PubMed ID: 28202186
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
7. Is selective 5-HT
Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
[TBL] [Abstract][Full Text] [Related]
8. The trigeminal nerve and augmentation of regional cerebral blood flow during experimental bacterial meningitis.
Weber JR; Angstwurm K; Bove GM; Bürger W; Einhäupl KM; Dirnagl U; Moskowitz MA
J Cereb Blood Flow Metab; 1996 Nov; 16(6):1319-24. PubMed ID: 8898707
[TBL] [Abstract][Full Text] [Related]
9. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis.
Koedel U; Lorenzl S; Gorriz C; Arendt RM; Pfister HW
J Cereb Blood Flow Metab; 1998 Jan; 18(1):67-74. PubMed ID: 9428307
[TBL] [Abstract][Full Text] [Related]
10. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human basilar artery contractile response to 5-HT and triptans.
Silva SA; Marques FB; Fontes Ribeiro CA
Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
13. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
Limmroth V; Kazarawa Z; Fritsche G; Diener HC
Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
[No Abstract] [Full Text] [Related]
14. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
15. [Highly selective beginning. Associated symptoms and side effects in retrospect].
MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
[No Abstract] [Full Text] [Related]
16. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
Lorenzl S; Koedel U; Pfister HW
Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
[TBL] [Abstract][Full Text] [Related]
17. Neurogenic inflammation in the context of migraine.
Williamson DJ; Hargreaves RJ
Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
Pfister HW; Koedel U; Lorenzl S; Tomasz A
Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
[TBL] [Abstract][Full Text] [Related]
20. Have the triptans fulfilled their promise?
Zagami AS
J Clin Neurosci; 2001 Sep; 8(5):476-7. PubMed ID: 11535025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
